Peptides
CA 2113121 A1 · Owner: Novartis Ag · Inventors: Macke, Helmut; Albert, Rainer
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
of the Invention, Somatostatin peptides bearing a chelating group selected from a bifunctional N4-chelating group particularly suitable for Tc, Rh, Cu, Co or Re-labelling, and a bifunctional polyaminopolycarboxylic acid chelating group are complexed with a .alpha.- .beta.-, .gamma.- or positron-emitting nuclide or a nuclide with Auger-e-cascades and are useful as radiopharmaceuticals.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 10, 1994. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 10, 2014.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 10, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.